Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus.
Ill effects from the condition can include fatigue, pain, neurological issues and even changes in mental health.
Initially, public health officials believed that only a small minority of people would suffer from long COVID-19. But some studies now indicate a majority of those infected with the coronavirus are experiencing long COVID-19 symptoms.
Still, estimates on the numbers of people with long COVID are all over the map.
Researchers from the Penn State College of Medicine found that more than half of COVID-19 survivors had long COVID-19.
Another study from the University of Arizona found that about 2 out of 3 people who experienced mild or moderate cases of coronavirus had long-lasting symptoms.
Other reports have been more conservative, estimating anywhere between 10 to 30 percent of those infected develop long-term symptoms. Those who experience ongoing symptoms from long COVID-19 have sometimes come to be known as COVID-19 long haulers.
One problem in figuring out how many people get long COVID-19 is defining it.
Apart from the wide range of symptoms, there is still debate over when a person is considered to have long COVID-19. Some health care authorities consider a patient to have the condition if symptoms persist after three to six weeks, while other think it should be considered on a longer basis.
Jim Heath, president and professor at the Institute for Systems Biology, is leading the Pacific Northwest consortium researching long COVID-19 as part of the National Institute of Health’s (NIH) RECOVER initiative, which is looking into the post-COVID-19 condition and potential ways of preventing and treating it.
Heath told The Hill that if one definition of long COVID-19 was being used — one in which symptoms lingered about four to six weeks after infection — then roughly half of those infected would be considered to have long COVID-19.
According to Heath, an estimate of 15 to 20 percent of coronavirus survivors experiencing long COVID-19 after six months was a reasonable “educated guess” and he added that there was evidence to support that rate of occurrence.
When reached for comment by The Hill, the NIH said initial studies have found that at least half of COVID-19 patients who were hospitalized reported “persistent weakness or fatigue” months after their recovery.
Studies on the prevalence of long COVID-19 have been “relatively few,” according to the NIH, and they have all focused on people who had symptomatic cases of COVID-19.
The NIH said numerous observational studies in both children and adults are being conducted to find potential treatments for long haulers. The agency has requested applications for new clinical trials to launch this summer to test potential ways of preventing and treating long COVID-19.
“In contrast to the wealth of prior knowledge that led to the vaccines for Sars-CoV-2 and a host of other viruses, there is much less known about what causes persistent symptoms following infectious illnesses or how to best treat them. As a consequence, there is more knowledge needed to fuel the scientific advances to come,” the NIH said.
News
Does Space-Time Really Exist?
Is time something that flows — or just an illusion? Exploring space-time as either a fixed “block universe” or a dynamic fabric reveals deeper mysteries about existence, change, and the very nature of reality. [...]
Unlocking hidden soil microbes for new antibiotics
Most bacteria cannot be cultured in the lab-and that's been bad news for medicine. Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil [...]
By working together, cells can extend their senses beyond their direct environment
The story of the princess and the pea evokes an image of a highly sensitive young royal woman so refined, she can sense a pea under a stack of mattresses. When it comes to [...]
Overworked Brain Cells May Hold the Key to Parkinson’s
Scientists at Gladstone Institutes uncovered a surprising reason why dopamine-producing neurons, crucial for smooth body movements, die in Parkinson’s disease. In mice, when these neurons were kept overactive for weeks, they began to falter, [...]
Old tires find new life: Rubber particles strengthen superhydrophobic coatings against corrosion
Development of highly robust superhydrophobic anti-corrosion coating using recycled tire rubber particles. Superhydrophobic materials offer a strategy for developing marine anti-corrosion materials due to their low solid-liquid contact area and low surface energy. However, [...]
This implant could soon allow you to read minds
Mind reading: Long a science fiction fantasy, today an increasingly concrete scientific goal. Researchers at Stanford University have succeeded in decoding internal language in real time thanks to a brain implant and artificial intelligence. [...]
A New Weapon Against Cancer: Cold Plasma Destroys Hidden Tumor Cells
Cold plasma penetrates deep into tumors and attacks cancer cells. Short-lived molecules were identified as key drivers. Scientists at the Leibniz Institute for Plasma Science and Technology (INP), working with colleagues from Greifswald University Hospital and [...]
This Common Sleep Aid May Also Protect Your Brain From Alzheimer’s
Lemborexant and similar sleep medications show potential for treating tau-related disorders, including Alzheimer’s disease. New research from Washington University School of Medicine in St. Louis shows that a commonly used sleep medication can restore normal sleep patterns and [...]
Sugar-Coated Nanoparticles Boost Cancer Drug Efficacy
A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials. Over a tenth of breast [...]
Nanoparticle-Based Vaccine Shows Promise in Fighting Cancer
In a study published in OncoImmunology, researchers from the German Cancer Research Center and Heidelberg University have created a therapeutic vaccine that mobilizes the immune system to target cancer cells. The researchers demonstrated that virus peptides combined [...]
Quantitative imaging method reveals how cells rapidly sort and transport lipids
Lipids are difficult to detect with light microscopy. Using a new chemical labeling strategy, a Dresden-based team led by André Nadler at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and [...]
Ancient DNA reveals cause of world’s first recorded pandemic
Scientists have confirmed that the Justinian Plague, the world’s first recorded pandemic, was caused by Yersinia pestis, the same bacterium behind the Black Death. Dating back some 1,500 years and long described in historical texts but [...]
“AI Is Not Intelligent at All” – Expert Warns of Worldwide Threat to Human Dignity
Opaque AI systems risk undermining human rights and dignity. Global cooperation is needed to ensure protection. The rise of artificial intelligence (AI) has changed how people interact, but it also poses a global risk to human [...]
Nanomotors: Where Are They Now?
First introduced in 2004, nanomotors have steadily advanced from a scientific curiosity to a practical technology with wide-ranging applications. This article explores the key developments, recent innovations, and major uses of nanomotors today. A [...]
Study Finds 95% of Tested Beers Contain Toxic “Forever Chemicals”
Researchers found PFAS in 95% of tested beers, with the highest levels linked to contaminated local water sources. Per- and polyfluoroalkyl substances (PFAS), better known as forever chemicals, are gaining notoriety for their ability [...]
Long COVID Symptoms Are Closer To A Stroke Or Parkinson’s Disease Than Fatigue
When most people get sick with COVID-19 today, they think of it as a brief illness, similar to a cold. However, for a large number of people, the illness doesn't end there. The World [...]
